UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
 
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 12)*
 
PENWEST PHARMACEUTICALS CO.
(Name of Issuer)
 
Common Stock, Par value $0.001
(Title of Class of Securities)
 
709754105
(CUSIP Number)
 
Kevin C. Tang
Tang Capital Management, LLC
4401 Eastgate Mall
San Diego, CA 92121
(858) 200-3830
(Name, Address and Telephone Number of Person Authorized to Receive Notice and Communications)
 
September 20, 2010
(Date of Event Which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D/A, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box.  x
 
Note:       Schedules filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits.   See Rule 13d-7(b) for other parties to whom copies are to be sent.
 
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 
 
CUSIP No. 709754105
13D/A
Page 2 of 6 Pages
 
 
1.
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
 
Tang Capital Partners, LP
 
2.
 
CHECK THE APPROPRIATE BOX IF A GROUP
(a) x  
(b) o  
 
3.
 
SEC USE ONLY
 
 
4.
 
SOURCES OF FUNDS
 
WC
 
5.
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or (e)      ¨
 
 
6.
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
DELAWARE
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 
7.
 
SOLE VOTING POWER
0  
 
8.
 
SHARED VOTING POWER
0
 
9.
 
SOLE DISPOSITIVE POWER
0  
 
10.
 
SHARED DISPOSITIVE POWER
0
 
11.
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
0
 
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES      ¨
 
13.
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
 
    0%
 
14.
 
TYPE OF REPORTING PERSON
 
PN
  
 
 
 

 
 
 
CUSIP No. 709754105
13D/A
Page 3 of 6 Pages
 
 
1.
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
 
Tang Capital Management, LLC
 
2.
 
CHECK THE APPROPRIATE BOX IF A GROUP
(a) x  
(b) o  
 
3.
 
SEC USE ONLY
 
 
4.
 
SOURCES OF FUNDS
 
WC
 
5.
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or (e)      ¨
 
 
6.
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
DELAWARE
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 
7.
 
SOLE VOTING POWER
0  
 
8.
 
SHARED VOTING POWER
0
 
9.
 
SOLE DISPOSITIVE POWER
0  
 
10.
 
SHARED DISPOSITIVE POWER
0
 
11.
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
0
 
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES      ¨
 
13.
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
 
    0%
 
14.
 
TYPE OF REPORTING PERSON
 
OO
  
 
 
 

 
 
 
CUSIP No. 709754105
13D/A
Page 4 of 6 Pages
 
 
1.
 
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
 
Kevin C. Tang
 
2.
 
CHECK THE APPROPRIATE BOX IF A GROUP
(a) x  
(b) o  
 
3.
 
SEC USE ONLY
 
 
4.
 
SOURCES OF FUNDS
 
PF, WC, OO
 
5.
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or (e)      ¨
 
 
6.
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
DELAWARE
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
 
7.
 
SOLE VOTING POWER
0
 
8.
 
SHARED VOTING POWER
0
 
9.
 
SOLE DISPOSITIVE POWER
0
 
10.
 
SHARED DISPOSITIVE POWER
0
 
11.
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
0
 
12.
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES      ¨
 
13.
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
 
    0%
 
14.
 
TYPE OF REPORTING PERSON
 
IN
  
 
 
 

 
 
CUSIP No. 709754105
13D/A
Page 5 of 6  Pages
 
Explanatory Note : This Amendment No. 12 relates to and amends the Statement of Beneficial Ownership on Schedule 13D of Tang Capital Partners, LP, a Delaware partnership, Tang Capital Management, LLC, a Delaware limited liability company and Kevin C. Tang, a United States citizen (each, a “Reporting Person” and collectively, the “Reporting Persons”), initially filed jointly by the Reporting Persons with the Securities and Exchange Commission on January 12, 2009 and amended February 19, 2009, March 3, 2009, March 10, 2009, March 12, 2009, March 30, 2009, April 28, 2009, June 19, 2009, February 5, 2010, May 28, 2010, June 30, 2010 and August 10, 2010 (as so amended the “Statement”), with respect to the Common Stock, $0.001 par value (the “Common Stock”), of Penwest Pharmaceuticals Co., a Washington corporation (the “Issuer”).

Items 4 and 5 of the Statement are hereby amended to the extent hereinafter expressly set forth.  All capitalized terms used and not expressly defined herein have the respective meanings ascribed to such terms in the Statement.

  ITEM 4.  Purpose of Transaction
 
Item 4 of the Statement is hereby amended to add the following:

On September 20, 2010, the Merger Sub accepted the tender of all of the shares of Common Stock held by the Reporting Persons, pursuant to the terms of the Offer. The Reporting Persons received the consideration for such tender from Merger Sub on September 23, 2010.


  ITEM 5.  Interest in Securities of the Issuer
 
Item 5 of the Statement is hereby amended and restated as follows:

Reference is made to Item 4 of the Statement.

As of September 20, 2010 the Reporting Persons ceased to be the beneficial owner of any securities of the Issuer.
 
 
 

 

CUSIP No. 709754105
13D/A
Page 6 of 6  Pages
 
 
 
SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
September 27, 2010
Date
 
 
Tang Capital Partners, LP
 
By: Tang Capital Management, LLC
 
By: /s/ Kevin C. Tang
    Kevin C. Tang, Manager
 
   
 
Tang Capital Management, LLC
 
By: /s/ Kevin C. Tang
    Kevin C. Tang, Manager
 
 
   
 
/s/ Kevin C. Tang
    Kevin C. Tang
 
 
Penwest (NASDAQ:PPCO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Penwest Charts.
Penwest (NASDAQ:PPCO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Penwest Charts.